Page 1 of Clinical Trials for Drug salmeterol and fluticasone propionate, 181 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma
Last Updated: June 3, 2010
Condition(s): Bronchial Asthma
2
Completed
Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications
Last Updated: October 9, 2008
Condition(s): Asthma
3
Active, not recruiting
Evaluation Inhaled Corticosteroids on Exhaled Nitric Oxide Gas Exchange
Last Updated: July 13, 2011
Condition(s): COPD
4
Completed
Pediatric Study to Evaluate Treatment of Persistent Moderate or Severe Asthma With the Association Fluticasone 250 Mcg/Dose and Salmeterol 50 Mcg/Dose - ADERE PROJECT
Last Updated: November 17, 2011
Condition(s): Asthma
5
Recruiting
Phase I Pharmacokinetic Study (SALBLOCK)
Last Updated: April 24, 2012
Condition(s): Healthy Volunteer Study
6
Terminated
No Resistance After Long Term Treatment SERETIDE
Last Updated: March 20, 2009
Condition(s): Asthma
7
Completed
Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)
Last Updated: July 14, 2011
Condition(s): Respiratory Disorders
8
Active, not recruiting
Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)
Last Updated: July 14, 2011
Condition(s): Respiratory Disorders
9
Recruiting
Comparison of Indacaterol 150 μg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 μg/500 μg Twice Daily (b.i.d.)
Last Updated: March 14, 2012
Condition(s): Chronic Obstructive Pulmonary Disease
10
Completed
Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma
Last Updated: April 21, 2010
Condition(s): Asthma
11
Completed
Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)
Last Updated: July 7, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease (COPD)
12
Completed
Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population
Last Updated: June 16, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
13
Completed
Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)
Last Updated: December 17, 2010
Condition(s): Asthma
14
Completed
A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 HFA Versus Fluticasone Propionate 100 HFA In Children With Asthma
Last Updated: August 30, 2010
Condition(s): Asthma
15
Completed
Influence Of Salmeterol Xinafoate/Fluticasone Propionate (50/500 µg BID) On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IV
Last Updated: February 2, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease (COPD)
16
Completed
Viapaed Study In Children And Adolescents With Asthma
Last Updated: March 17, 2011
Condition(s): Asthma
17
Completed
Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)
Last Updated: April 30, 2012
Condition(s): Asthma
18
Completed
Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease
Last Updated: January 19, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
19
Completed
Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies
Last Updated: August 4, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
20
Terminated
ADVAIR DISKUS (Fluticasone Propionate/Salmeterol) Versus SEREVENT DISKUS (Salmeterol) On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease
Last Updated: October 1, 2010
Condition(s): Chronic Obstructive Pulmonary Disease (COPD)

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+salmeterol+and+fluticasone+propionate

Page 1 of Clinical Trials for Drug salmeterol and fluticasone propionate, 181 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About